WGSWW Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -30.4%
- Operating margin
- -25.6%
- Revenue growth YoY
- 17.4%
- Dividend yield
- —
- Beta
- 1.97
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
6 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About GeneDx Holdings Corp.
Company profileGeneDx Holdings Corp. (Ticker: WGSWW) is at the forefront of the genomics sector, specializing in genomic testing and precision medicine aimed at diagnosing rare and complex genetic disorders. Utilizing advanced sequencing technologies and an extensive genetic knowledge repository, GeneDx provides healthcare professionals with essential diagnostic resources that facilitate tailored treatment strategies. The company's diverse genetic testing portfolio, combined with strategic partnerships in the healthcare space, enhances its competitive positioning and underscores its commitment to…
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- NORTH TOWER, STAMFORD, CT
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
